Results 41 to 50 of about 11,186 (218)

HALLAZGOS MAS FRECUENTES POR TOMOGRAFIA AXIAL COMPUTADA EN PACIENTES CON DIAGNOSTICO CLINICO DE LINFOMA EN CAVIDAD ABDOMINAL EN EL CENTRO MEDICO ISSEMYM TOLUCA “ARTURO MONTIEL ROJAS” DEL PERIODO COMPRENDIDO DE ENERO DEL 2015 A AGOSTO DE 2016” [PDF]

open access: yes, 2017
RESUMEN La prevalencia de la afectación extranodal en el linfoma no Hodgkin y la enfermedad de Hodgkin ha aumentado en la última década, extranodal se refiere a la infiltración linfomatosa de sitios anatómicos distintos de los ganglios linfáticos ...
GUTIERREZ SANCHEZ, ROGELIO   +1 more
core  

Brexucabtagene autoleucel in‐vivo expansion and BTKi refractoriness have a negative influence on progression‐free survival in mantle cell lymphoma: Results from CART‐SIE study

open access: yesBritish Journal of Haematology, Volume 206, Issue 2, Page 644-651, February 2025.
In this prospective, observational, real‐world, multicentre study, we evaluated 106 patients affected by mantle cell lymphoma. The patients were treated with the anti‐CD19 CAR T‐cell therapy Brexucabtagene autoleucel (brexu‐cel). Our study corroborated the association between in‐vivo CAR T‐cell expansion and progression‐free survival (PFS).
Federico Stella   +24 more
wiley   +1 more source

High‐grade B‐cell lymphoma not otherwise specified, with diffuse large B‐cell lymphoma gene expression signatures: Genomic analysis and potential therapeutics

open access: yesAmerican Journal of Hematology, Volume 100, Issue 1, Page 10-22, January 2025.
Abstract High‐grade B‐cell lymphoma not otherwise specified (HGBCL, NOS) has overlapping morphological and genetic features with diffuse large B‐cell lymphoma (DLBCL) and Burkitt lymphoma (BL), leading to uncertainty in its diagnosis and clinical management.
Waseem Lone   +29 more
wiley   +1 more source

LINFOMA NO HODGKIN PRIMARIO DE LA MAMA

open access: yesRevista chilena de obstetricia y ginecología, 2003
El linfoma no Hodgkin primario de la mama es una patología poco frecuente, constituye menos del 0,5% de todos los tumores mamarios malignos. Debido a que carecen de características propias, tanto clínicas, mamográficas y ultrasonográficas, resulta muy difícil establecer el diagnóstico preoperatorio, confundiéndose con el carcinoma mamario, incluso en ...
Pardo G, Mario, Burgos S, Nelson
openaire   +4 more sources

ANÁLISE DOS DIAGNÓSTICOS DE LINFOMA DE HODGKIN E NÃO HODGKIN NO HOSPITAL DE REFERÊNCIA DA PARAÍBA: IMPACTO DA PANDEMIA DE COVID-19

open access: yesHematology, Transfusion and Cell Therapy
Objetivo: Correlacionamos os diagnósticos de linfoma de Hodgkin e linfoma não - Hodgkin em pacientes atendidos no hospital de referência oncológica da Paraíba, durante período 2019/2023, analisando as variáveis pré e pós-pandemia de COVID-19 e influência
MAOM Teixeira   +8 more
doaj   +1 more source

Linfoma de Hodgkin na criança e no adolescente: análise em um centro de referência estadual [PDF]

open access: yes, 2011
Trabalho de Conclusão de Curso - Universidade Federal de Santa Catarina. Curso de Medicina.
Soldateli, Gustavo
core  

GPRASP protein deficiency triggers lymphoproliferative disease by affecting B‐cell differentiation

open access: yesHemaSphere, Volume 8, Issue 11, November 2024.
Abstract Gprasp1 and Gprasp2 encode proteins that control the stability and cellular trafficking of CXCR4, a master regulator of hematopoiesis whose dynamic regulation is required for appropriate trafficking of B‐cells in the germinal center (GC). Here, we report that Gprasp1 and Gprasp2‐deficient B‐cells accumulate in the GC and show transcriptional ...
Antonio Morales‐Hernández   +6 more
wiley   +1 more source

Linfomas primitivos gastrointestinales no Hodgkinianos

open access: yesCirugía del Uruguay, 1991
Se revisaron retrospectivamente los casos de linfomas primitivos gastrointestinales no Hodgkinianos del trienio 1987 a 1989 tratados en el Hospital Maciel, haciendo el análisis de la presentación clínica, las características evolutivas y el estudio ...
Dante Pastro   +3 more
doaj  

Targeting CD25+ lymphoma cells with the antibody–drug conjugate camidanlumab tesirine as a single agent or in combination with targeted agents

open access: yesBritish Journal of Haematology, Volume 205, Issue 5, Page 1873-1882, November 2024.
Camidanlumab tesirine is a CD25‐specific antibody‐drug conjugate employing SG3199, a highly cytotoxic DNA minor groove cross‐linking pyrrolobenzodiazepine dimer, with cytotoxic activity in lymphoma cells. The addition of other drugs targeting additional pathways can synergize with camidanlumab tesirine. Created with Biorende.
Filippo Spriano   +12 more
wiley   +1 more source

Características epidemiológicas, clínicas y patológicas de los linfomas en el Hospital Nacional Cayetano Heredia del año 1998 al 2008

open access: yesActa Médica Peruana, 2011
bjetivo: Conocer las características epidemiológicas, clínicas y patológicas de los pacientes con linfoma diagnosticados en el Hospital Nacional Cayetano Heredia. Material y métodos: Se realizó un estudio descriptivo, retrospectivo, tipo serie de casos
Juan José Padilla Valdez   +2 more
doaj  

Home - About - Disclaimer - Privacy